Yahoo Web Search

Search results

    • This Unpopular Dividend Stock Is a Buy

      This Unpopular Dividend Stock Is a Buy

      Motley Fool via Yahoo Finance· 17 hours ago

      In March, for example, the pharma giant completed its acquisition of Karuna Therapeutics, adding the potential blockbuster schizophrenia treatment KarXT...